472 related articles for article (PubMed ID: 18501234)
1. Normal fasting plasma glucose and risk of type 2 diabetes diagnosis.
Nichols GA; Hillier TA; Brown JB
Am J Med; 2008 Jun; 121(6):519-24. PubMed ID: 18501234
[TBL] [Abstract][Full Text] [Related]
2. Normal fasting plasma glucose levels and type 2 diabetes in young men.
Tirosh A; Shai I; Tekes-Manova D; Israeli E; Pereg D; Shochat T; Kochba I; Rudich A;
N Engl J Med; 2005 Oct; 353(14):1454-62. PubMed ID: 16207847
[TBL] [Abstract][Full Text] [Related]
3. The incidence of heart failure among nondiabetic patients with and without impaired fasting glucose.
Nichols GA; Koro CE; Kolatkar NS
J Diabetes Complications; 2009; 23(3):224-8. PubMed ID: 18413158
[TBL] [Abstract][Full Text] [Related]
4. [What will be the proper criteria for impaired fasting glucose for Korean men? Based on medical screening data from a general hospital].
Ryu S; Chang YS; Kim DI; Suh BS; Kim WS
J Prev Med Public Health; 2005 May; 38(2):203-7. PubMed ID: 16315759
[TBL] [Abstract][Full Text] [Related]
5. Levels of plasma fibrinogen and d-dimer in patients with impaired fasting glucose.
Coban E; Sari R; Ozdogan M; Akcit F
Exp Clin Endocrinol Diabetes; 2005 Jan; 113(1):35-7. PubMed ID: 15662593
[TBL] [Abstract][Full Text] [Related]
6. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
Barr EL; Zimmet PZ; Welborn TA; Jolley D; Magliano DJ; Dunstan DW; Cameron AJ; Dwyer T; Taylor HR; Tonkin AM; Wong TY; McNeil J; Shaw JE
Circulation; 2007 Jul; 116(2):151-7. PubMed ID: 17576864
[TBL] [Abstract][Full Text] [Related]
7. Increases in body mass index, even within non-obese levels, raise the risk for Type 2 diabetes mellitus: a follow-up study in a Japanese population.
Nagaya T; Yoshida H; Takahashi H; Kawai M
Diabet Med; 2005 Aug; 22(8):1107-11. PubMed ID: 16026381
[TBL] [Abstract][Full Text] [Related]
8. The sequential changes in the fasting plasma glucose levels within normoglycemic range predict type 2 diabetes in healthy, young men.
Park YW; Chang Y; Sung KC; Ryu S; Sung E; Kim WS
Diabetes Res Clin Pract; 2006 Sep; 73(3):329-35. PubMed ID: 16600415
[TBL] [Abstract][Full Text] [Related]
9. Does the new American Diabetes Association definition for impaired fasting glucose improve its ability to predict type 2 diabetes mellitus in Spanish persons? The Asturias Study.
Valdés S; Botas P; Delgado E; Alvarez F; Cadórniga FD
Metabolism; 2008 Mar; 57(3):399-403. PubMed ID: 18249214
[TBL] [Abstract][Full Text] [Related]
10. Physical activity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation.
Hu G; Lindström J; Valle TT; Eriksson JG; Jousilahti P; Silventoinen K; Qiao Q; Tuomilehto J
Arch Intern Med; 2004 Apr; 164(8):892-6. PubMed ID: 15111376
[TBL] [Abstract][Full Text] [Related]
11. Direct, progressive association of cardiovascular risk factors with incident proteinuria: results from the Korea Medical Insurance Corporation (KMIC) study.
Jee SH; Boulware LE; Guallar E; Suh I; Appel LJ; Miller ER
Arch Intern Med; 2005 Oct; 165(19):2299-304. PubMed ID: 16246998
[TBL] [Abstract][Full Text] [Related]
12. Alcohol consumption and higher incidence of impaired fasting glucose or type 2 diabetes in obese Korean men.
Roh WG; Shin HC; Choi JH; Lee YJ; Kim K
Alcohol; 2009 Dec; 43(8):643-8. PubMed ID: 20004342
[TBL] [Abstract][Full Text] [Related]
13. Factors related to the development of diabetes during a 20-year follow-up. A prospective study in a homogeneous group of middle-aged men.
Strandberg TE; Salomaa V
Nutr Metab Cardiovasc Dis; 2000 Oct; 10(5):239-46. PubMed ID: 11213532
[TBL] [Abstract][Full Text] [Related]
14. How to minimize missing those subjects with high 2HR plasma glucose but 'normal' fasting plasma glucose levels?
Ko GT; Cockram CS; Chan JC
J Med; 2001; 32(1-2):53-65. PubMed ID: 11321888
[TBL] [Abstract][Full Text] [Related]
15. The relationship between resting heart rate and atherosclerosis risk factors.
Piwońska A; Piotrowski W; Broda G; Drygas W; Głuszek J; Zdrojewski T; Kozakiewicz K; Stepaniak U; Bandosz P
Kardiol Pol; 2008 Oct; 66(10):1069-75; discussion 1076-8. PubMed ID: 19006028
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease.
Tenenbaum A; Motro M; Fisman EZ; Schwammenthal E; Adler Y; Goldenberg I; Leor J; Boyko V; Mandelzweig L; Behar S
Circulation; 2004 May; 109(18):2197-202. PubMed ID: 15123532
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice.
Kim SH; Chunawala L; Linde R; Reaven GM
J Am Coll Cardiol; 2006 Jul; 48(2):293-7. PubMed ID: 16843178
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of glycemia, body size, insulin resistance and the risk of hypertension in Mauritius.
Boyko EJ; Shaw JE; Zimmet PZ; Chitson P; Tuomilehto J; Alberti KG
J Hypertens; 2008 Sep; 26(9):1742-9. PubMed ID: 18698207
[TBL] [Abstract][Full Text] [Related]
19. Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study.
Valdés S; Botas P; Delgado E; Alvarez F; Cadórniga FD
Diabetes Care; 2007 Sep; 30(9):2258-63. PubMed ID: 17536076
[TBL] [Abstract][Full Text] [Related]
20. Type 2 diabetes and impaired fasting blood glucose in rural Bangladesh: a population-based study.
Hussain A; Vaaler S; Sayeed MA; Mahtab H; Ali SM; Khan AK
Eur J Public Health; 2007 Jun; 17(3):291-6. PubMed ID: 17008328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
